UNSPSC 51385605: Fendosal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Z709558TZ, chemically known as 5-(4,5-dihydro-2-phenyl-3h-benz(e)indol-3-yl)salicylic acid but generally known as fendosal, which bears US NIH Compound Identifier 40821. European Medicines Agency schedules Fendosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07555MIG.

UNSPSC 51385605 Fendosal, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for public health and emergency response programs. Recent solicitations under this code show state and local bodies buying naloxone and drug deactivation systems for community health initiatives, opioid response, and overdose prevention. The work encompasses procurement of finished pharmaceutical inventory with delivery obligations to designated health facilities, typically on annual or multi-year contracts with quarterly or scheduled replenishment cycles. Issuing bodies include county health departments and public health authorities managing substance abuse and emergency medical response programs.

Seminole County, Florida is the primary recent buyer on record, having posted an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract terms include a two-year initial period with one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify, drug-free workplace certification, and insurance coverage. Vendors bear shipping and delivery costs. While the source shows limited recent activity, the Florida opportunity demonstrates active procurement in the opioid-response and public health space, though geographic spread and repeat-buyer patterns across other states are not supported by the available data.